Literature DB >> 16420287

Brain-gut connections in functional GI disorders: anatomic and physiologic relationships.

M P Jones1, J B Dilley, D Drossman, M D Crowell.   

Abstract

Understanding the neural regulation of gut function and sensation makes it easier to understand the interrelatedness of emotionality, symptom-attentive behavior or hypervigilance, gut function and pain. The gut and the brain are highly integrated and communicate in a bidirectional fashion largely through the ANS and HPA axis. Within the CNS, the locus of gut control is chiefly within the limbic system, a region of the mammalian brain responsible for both the internal and external homeostasis of the organism. The limbic system also plays a central role in emotionality, which is a nonverbal system that facilitates survival and threat avoidance, social interaction and learning. The generation of emotion and associated physiologic changes are the work of the limbic system and, from a neuroanatomic perspective, the 'mind-body interaction' may largely arise in this region. Finally, the limbic system is also involved in the 'top down' modulation of visceral pain transmission as well as visceral perception. A better understanding of the interactions of the CNS, ENS and enteric immune system will significantly improve our understanding of 'functional' disorders and allow for a more pathophysiologic definition of categories of patients currently lumped under the broad umbrella of FGID.

Entities:  

Mesh:

Year:  2006        PMID: 16420287     DOI: 10.1111/j.1365-2982.2005.00730.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  93 in total

1.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

2.  Avoiding unnecessary surgery in irritable bowel syndrome.

Authors:  George F Longstreth
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

3.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

Authors:  Ricard Farré; Rita De Vos; Karel Geboes; Kristine Verbecke; Pieter Vanden Berghe; Inge Depoortere; Kathleen Blondeau; Jan Tack; Daniel Sifrim
Journal:  Gut       Date:  2007-02-01       Impact factor: 23.059

4.  Evidence of overlapping genetic diathesis of panic attacks and gastrointestinal disorders in a sample of male twin pairs.

Authors:  Mark W Logue; Sarah R Bauver; William S Kremen; Carol E Franz; Seth A Eisen; Ming T Tsuang; Michael D Grant; Michael J Lyons
Journal:  Twin Res Hum Genet       Date:  2011-02       Impact factor: 1.587

5.  Serum correlates of the placebo effect in irritable bowel syndrome.

Authors:  E Kokkotou; L A Conboy; D C Ziogas; M T Quilty; J M Kelley; R B Davis; A J Lembo; T J Kaptchuk
Journal:  Neurogastroenterol Motil       Date:  2009-12-22       Impact factor: 3.598

Review 6.  In vitro and in vivo models of acute alcohol exposure.

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

7.  Alimentary Epigenetics: A Developmental Psychobiological Systems View of the Perception of Hunger, Thirst and Satiety.

Authors:  Christopher Harshaw
Journal:  Dev Rev       Date:  2008-12-01

8.  Ghrelin and functional dyspepsia.

Authors:  Takashi Akamizu; Hiroshi Iwakura; Hiroyuki Ariyasu; Kenji Kangawa
Journal:  Int J Pept       Date:  2010-01-12

9.  The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.

Authors:  Pontus Karling; Åke Danielsson; Mikael Wikgren; Ingegerd Söderström; Jurgen Del-Favero; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

10.  Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study.

Authors:  Anthony C Johnson; Brent Myers; Jelena Lazovic; Rheal Towner; Beverley Greenwood-Van Meerveld
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.